About us

Noa Therapeutics is a preclinical biotech company leveraging a systems biology approach to accelerate design of tailored multimodal therapeutics for complex inflammatory diseases. With discrete expertise in dermal therapeutics, Noa is advancing a first-use case in Atopic Dermatitis. Noa’s lead ID, NOA-101, simultaneously addresses three constructive targets to address persistent unmet needs to displace multiple major players within the $5.0B, 10.1% CAGR, US Market; paving the way for pipeline expansion into >$70B inflammatory disease markets.

Program engagement


Carla Spina

CEO & Co-Founder

Serena Mandla

CSO & Co-Founder


Intellectual Property




Celebrate BIG ideas that make a bigger impact at The Big DiF, Innovation Factory’s annual open house and client showcase. Join 250+ people from the Hamilton-Halton community to celebrate entrepreneurship and innovation.

Join Innovation Factory's Annual Open House - The Big DiF!

Network with 250+ industry professionals, discover emerging solutions from our innovators, and celebrate entrepreneurship within the Hamilton-Halton ecosystem.

May 9, 2024 | 4:00pm – 8:00pm | Hamilton, Ontario